Vir Biotechnology, Inc.(VIR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VIR Vir Biotechnology, Inc.

Closed 10-05 16:00:00 EDT

11.78

+0.61

+5.46%

盘后11.75

-0.03-0.25%

19:30 EDT

High11.87	Low10.92	Vol3.15M
Open11.17	D1 Closing11.17	Amplitude8.50%
Mkt Cap1.99B	Tradable Cap1.53B	Total Shares168.65M
T/O36.44M	T/O Rate2.42%	Tradable Shares130.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"VIR","market":"US","secType":"STK","nameCN":"Vir Biotechnology, Inc.","latestPrice":11.78,"timestamp":1791230400000,"preClose":11.17,"halted":0,"volume":3147232,"hourTrading":{"tag":"盘后","latestPrice":11.75,"preClose":11.78,"latestTime":"19:30 EDT","volume":151832,"amount":1789612.236,"timestamp":1791243003015,"change":-0.03,"changeRate":-0.002547,"amplitude":0.011036},"delay":0,"changeRate":0.05461056401074301,"floatShares":130000000,"shares":168651974,"eps":-1.697185,"marketStatus":"Closed","change":0.61,"latestTime":"10-05 16:00:00 EDT","open":11.17,"high":11.8699,"low":10.92,"amount":36440477.49056,"amplitude":0.08504,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.697185,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791273600000},"marketStatusCode":5,"adr":0,"listingDate":1570766400000,"exchange":"NASDAQ","adjPreClose":11.17,"preHourTrading":{"tag":"盘前","latestPrice":11.1997,"preClose":11.17,"latestTime":"08:41 EDT","volume":7,"amount":76.8285,"timestamp":1791204114710,"change":0.0297,"changeRate":0.002659,"amplitude":0.013214},"postHourTrading":{"tag":"盘后","latestPrice":11.75,"preClose":11.78,"latestTime":"19:30 EDT","volume":151832,"amount":1789612.236,"timestamp":1791243003015,"change":-0.03,"changeRate":-0.002547,"amplitude":0.011036},"volumeRatio":1.667354,"optionData":{"bulkOrders":[{"symbol":"VIR","call":true,"expireDate":1799989200000,"strike":"13.0","timestamp":1791225534041,"price":1.35,"volume":1500,"amount":202500,"type":"+"}]},"impliedVol":0.9003,"impliedVolPercentile":0.8088},"requestUrl":"/m/hq/s/VIR","defaultTab":"news","newsList":[{"id":"1165041702","title":"One Molecule, Three Diseases, $1.55 Billion — Inside CSL's Bet","url":"https://stock-news.laohu8.com/highlight/detail?id=1165041702","media":"Bellwether Stocks Movement","labels":[],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1165041702?lang=en_us&edition=fundamental","pubTime":"2026-10-05 15:29","pubTimestamp":1791185371,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3140.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3140.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"One Molecule, Three Diseases, $1.55 Billion — Inside CSL's Bet","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["H02.SI","MRNA","BMY","AMGN","VERU","CSLLY","1H3.SI","NVS","546.SI","41A.SI","MRK","5NG.SI","BSL.SI","AZN","NVO","SNY","LLY","AW9U.SI","BNTX","JNJ","A50.SI","BIIB","PFE","GILD","AP4.SI","VIR","GSK","NVAX","REGN","ABBV","ABT","C2PU.SI"],"isVideo":true,"video":{"duration":217,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3140.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3140.webp","audio_url":"https://static.tigerbbs.com/035eb06a923df5523989f56e6fc14c4d.mp3","isAI":true},"gpt_icon":0},{"id":"1124786704","title":"Merck Doubled Off Its Lows — And Analysts Still See More Room","url":"https://stock-news.laohu8.com/highlight/detail?id=1124786704","media":"Bellwether Stocks Movement","labels":[],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1124786704?lang=en_us&edition=fundamental","pubTime":"2026-10-05 14:41","pubTimestamp":1791182489,"startTime":"0","endTime":"0","summary":"","market":"nz","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3135.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3135.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Merck Doubled Off Its Lows — And Analysts Still See More Room","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","SQQQ","SSO","DOG","MRK","VIR","REGN","ELIS","UPRO","VOO","QQQ","JNJ","MRNA","SPUU","DXD","DMAX","LLY","GSKH","ELIL","JPMO","DIA","LLYX","SPXU","NVAX",".SPX","MRNX","NVOH","SDOW","MMAX","GSK","SNY","SPXL","BIIB","DDM",".IXIC","JPM","AMGN","SPY","TQQQ","YSPY","AZN","NVOX","SDS","SPYM","HIBL","NVO","PFE","IVV","LLII","SPYU","NVS","VERU","SPYH","SMAX","UDOW",".DJI","BMY","SPXS","SPDN","SPYQ","JPO","MRNY","NVOC","BNTX","ABBV","SH","ABT"],"isVideo":true,"video":{"duration":182,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3135.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3135.webp","audio_url":"https://static.tigerbbs.com/d492d9882b1cd5d0c5306026a8f1963f.mp3","isAI":true},"gpt_icon":0},{"id":"1157208455","title":"CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1157208455","media":"Bellwether Stocks Movement","labels":[],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1157208455?lang=en_us&edition=fundamental","pubTime":"2026-10-05 10:38","pubTimestamp":1791167898,"startTime":"0","endTime":"0","summary":"","market":"nz","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3125.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3125.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSLLY","GILD","MRK","VIR","REGN","ELIS","JNJ","MRNA","LLY","GSKH","ELIL","LLYX","NVAX","MRNX","NVOH","GSK","SNY","BIIB","AMGN","AZN","NVOX","NVO","PFE","LLII","VERU","NVS","BMY","MRNY","NVOC","BNTX","ABBV","ABT"],"isVideo":true,"video":{"duration":229,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3125.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3125.webp","audio_url":"https://static.tigerbbs.com/c84a44b957cb1cda4f39d165f739b07a.mp3","isAI":true},"gpt_icon":0},{"id":"2673294081","title":"Vir to Present Expanded Phase 2 Solstice Data on Elebsiran-Tobevibart Combo in Hepatitis Delta at AASLD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673294081","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673294081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:06","pubTimestamp":1791230793,"startTime":"0","endTime":"0","summary":"Vir to present expanded Phase 2 SOLSTICE data on elebsiran-tobevibart combo in hepatitis delta at AASLD 2026Vir Biotechnology flagged expanded Phase 2 SOLSTICE results for elebsiran with tobevibart in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL8gq1MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VIR","BK4585","BK4535","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151971109","title":"Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1151971109","media":"Macro World","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151971109?lang=en_us&edition=fundamental","pubTime":"2026-10-03 17:22","pubTimestamp":1791019366,"startTime":"0","endTime":"0","summary":"","market":"nz","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3081.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3081.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","MRK","ELIS","NVOH","BMY","BIIB","BAYRY","NVOX","PFE","MRNY","AZN","LLY","LLII","SNY","JNJ","GILD","NVO","MRNX","ABT","GSKH","ELIL","NVAX","NVOC","AMGN","BNTX","NVS","VIR","GSK","MRNA","REGN","VERU","LLYX"],"isVideo":true,"video":{"duration":206,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3081.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3081.webp","audio_url":"https://static.tigerbbs.com/f1bbc2b54742b92aafc704bc4d0c576c.mp3","isAI":true},"gpt_icon":0},{"id":"1198460816","title":"23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook","url":"https://stock-news.laohu8.com/highlight/detail?id=1198460816","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198460816?lang=en_us&edition=fundamental","pubTime":"2026-10-03 16:06","pubTimestamp":1791014787,"startTime":"0","endTime":"0","summary":"","market":"nz","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3076.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3076.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","MRK","VIR","REGN","ELIS","JNJ","MRNA","LLY","GSKH","ELIL","LLYX","NVAX","MRNX","NVOH","GSK","SNY","BIIB","AMGN","AZN","NVOX","NVO","PFE","LLII","VERU","NVS","BMY","MRNY","NVOC","BNTX","ABBV","ABT"],"isVideo":true,"video":{"duration":261,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3076.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3076.webp","audio_url":"https://static.tigerbbs.com/5f9a45d52af3674e966786287f89b42c.mp3","isAI":true},"gpt_icon":0},{"id":"1124840365","title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1124840365","media":"Options & Short Sell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124840365?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:11","pubTimestamp":1790932272,"startTime":"0","endTime":"0","summary":"","market":"sg","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3059.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","BEAM","NVS","DNA","BNTX","SNY","RXRX","JNJ","MRNX","MRNY","VIR","ABBV","TEM","ABSI","AMGN","VERU","NVO","GSK","BMY","TEMT","LLII","GSKH","NVAX","SBIO","ELIL","GILD","MRNA","AZN","ABT","PFE","REGN","NVOC","TEMC","TXG","ELIS","LLYX","CRSP","NVOH","RBOT","BIIB","LLY","MRK","XBI","GERM","IDNA"],"isVideo":true,"video":{"duration":213,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3059.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","audio_url":"https://static.tigerbbs.com/1c89c593761ab28aabf1a552eb3a775b.mp3","isAI":true},"gpt_icon":0},{"id":"2672752471","title":"Vir Biotechnology Names Aziz Sawaf as CFO Effective Oct. 5, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752471","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752471?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:31","pubTimestamp":1790857866,"startTime":"0","endTime":"0","summary":"Vir Biotechnology names Aziz Sawaf as CFO effective Oct. 5, 2026Vir Biotechnology appointed Aziz Sawaf as executive vice president and chief financial officer, effective Oct. 5, 2026.Sawaf will overse","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL7MZVyh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948897.HKD","LU0058720904.USD","LU1066051498.USD","LU2357627491.SGD","BBH","LU0234570918.USD","LU1037948541.HKD","TMED","LU0965509283.SGD","BK4566","IE0002270589.USD","LU0965509010.AUD","LU0889565916.HKD","LU2324357040.USD","LU1066053197.SGD","BK4588","ZYME","IE00B3T34201.USD","SG9999015945.SGD","IBB","IE00B7SZLL34.SGD","BK4585","LU0965508806.USD","IE00B19Z3B42.SGD","VIR","BK4139","LU2087621335.USD","TBXU","IBBQ","IE00BZ1G4Q59.USD","LU1674673691.USD","BK4532","LU0859254822.USD","MEDI","BMED","LU1571399168.USD","BK4583","LU1778281490.HKD","LU1430594728.SGD","LU0861579265.USD","LU2468319806.SGD","SG9999015952.SGD","LU0320765992.SGD","BK4578","LU0965509101.SGD","BIB","LU2089984988.USD","GILD","LU1674673428.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672675248","title":"Vir Biotechnology Appoints Aziz Sawaf as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2672675248","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672675248?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:30","pubTimestamp":1790857802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA4LKBSP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VIR","BK4585","BK4139","BK4535","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127378311","title":"AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=1127378311","media":"Options & Short Sell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127378311?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:44","pubTimestamp":1790642670,"startTime":"0","endTime":"0","summary":"","market":"uk","thumbnail":"https://static.tigerbbs.com/92728b90ee3a8a92bf786a931a559165","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/92728b90ee3a8a92bf786a931a559165"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCGN","PFE","GILD","VERU","GSK","SMMT","NVAX","MRNX","AZN","VIR","ELIL","SNY","ABT","MRNY","BNTX","GSKH","MRK","VXRT","MRNA","LLYX","JNJ","ELIS","REGN","LLII","IBIO","LLY"],"isVideo":true,"video":{"duration":84,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/2802.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/2802.webp","audio_url":"https://static.tigerbbs.com/5b10203ee8e7af70c985cde92862eb24.mp3","isAI":true},"gpt_icon":0},{"id":"1196528349","title":"Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196528349","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196528349?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:38","pubTimestamp":1790260696,"startTime":"0","endTime":"0","summary":"Pharmaceutical stocks jumped. Moderna, Eli Lilly rose over 3%; Novavax, Pfizer rose around 2%; Merck, Novo Nordisk rose over 1%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","ABBV","BNTX","MRK","NVOH","VIR","GSK","PFE","NVO","NVOC","VERU","GSKH","BIIB","ABT","LLYX","AMGN","JNJ","NVS","NVAX","ELIL","BMY","MRNX","REGN","LLII","MRNA","ELIS","LLY","MRNY","SNY","NVOX","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669167025","title":"Vir Biotechnology (VIR) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2669167025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669167025?lang=en_us&edition=fundamental","pubTime":"2026-09-22 01:57","pubTimestamp":1790013427,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Vir Biotechnology, with a price target of $20.00. Truc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/vir-biotechnology-vir-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/vir-biotechnology-vir-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664888264","title":"Vir Biotechnology CEO to Join Morgan Stanley Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664888264","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664888264?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:07","pubTimestamp":1788206851,"startTime":"0","endTime":"0","summary":"Vir Biotechnology CEO to join Morgan Stanley Global Healthcare Conference fireside chatVir Biotechnology will join the Morgan Stanley 24th Annual Global Healthcare Conference on Sept. 14.CEO Marianne ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL7p95Pq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0234570918.USD","LU0158827948.USD","LU2028103732.USD","LU0795875086.SGD","VIR","IE00B775SV38.USD","LU2357305700.SGD","LU1074936037.SGD","LU1244550221.USD","KBWB","LU2264538146.SGD","LU0320765646.SGD","LU2133065610.SGD","LU1988902786.USD","BK4516","LU0390134368.USD","LU2487616109.SGD","LU1732800096.USD","LU1244550577.SGD","LU0795875169.SGD","IAI","LU0225283273.USD","LU0006306889.USD","LU0912757837.SGD","BK4127","LU0053666078.USD","LU1720051108.HKD","LU2347655156.SGD","LU2271345857.HKD","LU2023251221.USD","LU0267386448.USD","BK4535","LU0106831901.USD","LU1720051017.SGD","BK4581","IE00BKVL7J92.USD","LU1791710582.SGD","BK4588","LU0971096721.USD","LU1244550494.USD","LU1989772840.SGD","LU0106261372.USD","LU0158827781.USD","LU1064131342.USD","LU1791710400.SGD","BK4139","LU0882574139.USD","LU1989772923.USD","IE00B3S45H60.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421261","title":"Vir Biotechnology on Track for Record Winning Streak","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421261?lang=en_us&edition=fundamental","pubTime":"2026-08-19 23:08","pubTimestamp":1787152080,"startTime":"0","endTime":"0","summary":"Vir Biotechnology, Inc.  is currently at $9.84, up $0.35 or 3.69%--Would be highest close since July 10, 2026, when it closed at $9.96--On pace for largest percent increase since July 2, 2026, when it rose 5.02%--Currently up nine consecutive days; up 12.26% over this period--Longest winning streak on record --Best nine day stretch since the nine days ending June 30, 2026, when it rose 18.35%--Up 13.63% month-to-date--Up 63.18% year-to-date--Down 88.15% from its all-time closing high of $83.07 on Jan. 27, 2021--Up 125.69% from 52 weeks ago , when it closed at $4.36--Down 11.27% from its 52-week closing high of $11.09 on April 20, 2026--Up 125.69% from its 52-week closing low of $4.36 on Aug. 20, 2025--Traded as high as $10.08; highest intraday level since July 10, 2026, when it hit $10.45--Up 6.22% at today's intraday high; largest intraday percent increase since Aug. 6, 2026, when it rose as much as 6.47%All data as of 11:06:05 AM ETSource: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4568","BK4535","BK4139","VIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660435171","title":"The Bull Case For Vir Biotechnology (VIR) Could Change Following A Sudden Swing To Quarterly Profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2660435171","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660435171?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:22","pubTimestamp":1786969378,"startTime":"0","endTime":"0","summary":"Vir Biotechnology, Inc. reported second-quarter 2026 results showing revenue of US$238.95 million versus US$1.21 million a year earlier, with net income of US$80.08 million replacing a net loss of US$110.96 million and earnings per share from continuing operations turning to US$0.48 basic and US$0.47 diluted.\nOver the first half of 2026, revenue rose to US$238.92 million from US$4.25 million, while the company reduced its net loss to US$45.62 million and sharply improved loss per share,...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vir/vir-biotechnology/news/the-bull-case-for-vir-biotechnology-vir-could-change-followi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vir/vir-biotechnology/news/the-bull-case-for-vir-biotechnology-vir-could-change-followi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","VIR","BK4535","BK4585","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156977","title":"Olema Pharmaceuticals Names Jason O’Byrne CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156977","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156977?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:05","pubTimestamp":1786619159,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals names Jason O’Byrne CFOOlema Pharmaceuticals named Jason O’Byrne chief financial officer as it prepares for pivotal OPERA-01 data and a potential first commercial launch.O’Byrne ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL2kwyYz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIR","BK4585","BK4568","BK4139","BK4505","OLMA","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657662680","title":"Vir Biotechnology Inc : Morgan Stanley Cuts Target Price to $25.00 from $27.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2657662680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657662680?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:55","pubTimestamp":1786013721,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nAZN4TC7AJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4535","BK4139","VIR","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657682432","title":"Vir Biotechnology price target lowered to $19 from $21 at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2657682432","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657682432?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:17","pubTimestamp":1786011428,"startTime":"0","endTime":"0","summary":"Leerink analyst Roanna Ruiz lowered the firm’s price target on Vir Biotechnology (VIR) to $19 from $21 and keeps an Outperform rating on the shares...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vir-biotechnology-price-target-lowered-to-19-from-21-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vir-biotechnology-price-target-lowered-to-19-from-21-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4535","VIR","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657686648","title":"Vir Biotechnology (VIR) Gets a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2657686648","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657686648?lang=en_us&edition=fundamental","pubTime":"2026-08-06 16:40","pubTimestamp":1786005628,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout maintained a Buy rating on Vir Biotechnology today and set a price target of $30.00. Darout covers the Healthcare sec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/vir-biotechnology-vir-gets-a-buy-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/vir-biotechnology-vir-gets-a-buy-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","BK4588","BK4585","LABU","VIR","BK4139","BK4535","BK4568","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657572761","title":"Vir Biotechnology, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657572761","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657572761?lang=en_us&edition=fundamental","pubTime":"2026-08-06 07:43","pubTimestamp":1785973416,"startTime":"0","endTime":"0","summary":"Vir Biotechnology, Inc. reports results for the quarter ended June 30 - Earnings SummaryVir Biotechnology, Inc.VIR.OQreported quarterly adjusted earnings of 47 cents per share for the quarter ended Ju","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4423Y4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VIR","BK4585","BK4568","BK4535"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vir.bio","stockEarnings":[{"period":"1week","weight":0.0478},{"period":"1month","weight":-0.0287},{"period":"3month","weight":0.1125},{"period":"6month","weight":0.2329},{"period":"1year","weight":0.9735},{"period":"ytd","weight":0.8524}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. The company was incorporated in 2016 and is headquartered in San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.442895},{"month":2,"riseRate":0.428571,"avgChangeRate":0.063735},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.106207},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.055273},{"month":5,"riseRate":0.571429,"avgChangeRate":0.040281},{"month":6,"riseRate":0.571429,"avgChangeRate":0.026907},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.059573},{"month":8,"riseRate":0.285714,"avgChangeRate":0.013869},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.095861},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.026854},{"month":11,"riseRate":0.857143,"avgChangeRate":0.105555},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.058058}],"exchange":"NASDAQ","name":"Vir Biotechnology, Inc.","nameEN":"Vir Biotechnology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vir Biotechnology, Inc.(VIR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Vir Biotechnology, Inc.(VIR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Vir Biotechnology, Inc.,VIR,Vir Biotechnology, Inc.股票,Vir Biotechnology, Inc.股票老虎,Vir Biotechnology, Inc.股票老虎国际,Vir Biotechnology, Inc.行情,Vir Biotechnology, Inc.股票行情,Vir Biotechnology, Inc.股价,Vir Biotechnology, Inc.股市,Vir Biotechnology, Inc.股票价格,Vir Biotechnology, Inc.股票交易,Vir Biotechnology, Inc.股票购买,Vir Biotechnology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vir Biotechnology, Inc.(VIR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Vir Biotechnology, Inc.(VIR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}